Skip to main content
SpringerLink
Log in

The dilemma of Jehovah's Witness children who need blood to survive

  • Articles
  • Published:
HEC Forum Aims and scope Submit manuscript

Summary

Medical researchers must continue to develop and test non-blood oxygen-transport products. Resources provided by the Jehovah's Witness Hospital Assistance Line must be consulted. Sickle cell researchers must continue to test non-blood treatment. Information about non-blood treatments must be disbursed. Ways to enhance parental comport as the laws further and further support children's best interest must be provided. Information regarding cultural diversity must be disseminated. Hospitals and healthcare agencies that have not done so must institute the use of ethics consulting or ethics committees. Nurse ethicists must continue development of the role of educating staff; mediation, arbitration and negotiation; problem solving; obtaining legal opinion; providing patient, family, or staff advocacy; and helping to reduce suffering on the part of the providers. Difficult ethical decisions should continue to be debated.

Were the staff at X Med Center correct in overriding parental wishes and breaking tenets of their faith? In the doctor's, nurse's lawyer's, and judge's view they were. The child, now eight years old, is alive and well. The stroke resolved, and imminent death averted. The parents' and child's views are not presently available. Whether the family is suffering from the child's loss of his relationship with God, or are secretly relieved in their hearts that they are not, like Rita Swan, mourning their dead son, is unknown. What is known, is that this was a difficult case for all involved, and that such cases will continue to present themselves in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rosam E. Personal communication with Hospital Information Services, Watchtower, Jehovah's Witnesses Organization. 1995; 25 Columbia Heights, Brooklyn, NY.

  2. Thurkauf GC. Understanding the beliefs of the Jehovah's Witnesses. Focus on Critical Care. 1989; 16(3):199–204.

    Google Scholar 

  3. Jonsen AJ, Siegler M, Winslade W. Clinical Ethics. New York, NY: Mcgraw-Hill; 1992.

    Google Scholar 

  4. Quintero C. Blood administration in pediatric Jehovah's Witnesses. Pediatric Nursing. 1993; 19(1):46–48.

    Google Scholar 

  5. Gaylin W, Macklin R (eds.) Who speaks for the child? The problems of proxy consent. New York, NY: Plenum Press; 1992.

    Google Scholar 

  6. Jehovah's Witnesses versus King County Hospital, 1967. Federal Supplement 278, 309 U.S. 598, 278 F. Suppl. 488, 1967, 488–508.

  7. Akingbola OA, Custer JR, Bunchman TE, Sedman AB. Management of severe anemia without transfusion in a pediatric Jehovah's Witness patient. Critical Care Medicine. 1994; 22(3):524–28.

    Google Scholar 

  8. Prince vs. Commonwealth of Massachusetts. Jan. 31, 1944. 321 U.S. 804, 64 S. Ct. 784.

  9. Mantooth M. Transfusing the children of Jehovah's Witnesses. Rush Presbyterian St. Luke's Medical Center Health Law Report, 1994; (1):1–2.

  10. Gardner B, Bivona J, Alfonso A, Herbsman H. Major surgery in Jehovah's Witnesses. New York State Journal of Medicine. 1976; 76:765–66.

    Google Scholar 

  11. Kelly AD. Aequanimitas. Canadian Medical Association Journal. 1967; 96:432.

    Google Scholar 

  12. Spence RK. Management of severe anemia without transfusion in a pediatric Jehovah's Witness patient (letter to the editor). Critical Care Medicine. 1995; 23(2):416–17.

    Google Scholar 

  13. Dixon JL, Smalley MG. Jehovah's Witnesses: The surgical/ethical challenge. Journal of American Medical Association. 1981; 246(21):2471–72.

    Google Scholar 

  14. North Eastern Reporter, 549, 2nd Series, 1990. In Re: E.G., a Minor, Supreme Court of Illinois, No. 66089, pp. 322–31.

  15. Children's Aid Society of Metropolitan Toronto v. F.R., Ontario Province Court, Family Division, 1988.

  16. Fox V. Caught between religion and medicine. AORN Journal 1990; 52(1):131–46.

    Google Scholar 

  17. Robb N. Ruling on Jehovah's Witness teen in New Brunswick may have “settled the law” for MDs. Canadian Medical Association Journal. 1994; 151(5):625–8.

    Google Scholar 

  18. Swan R. The law should protect all children. Journal of Christian Nursing. Spring 1987; 40.

  19. May L. Challenging medical authority: The refusal of treatment by Christian Scientists. Hastings Center Report. 1995; 25(1):15–21.

    Google Scholar 

  20. Ohene-Frempong K. Stroke in sickle cell disease: Demographic, clinical and therapeutic considerations. Seminars in Hematology. 1991; 28(3):213–9.

    Google Scholar 

  21. Al-Momen AM. Recombinant human erythropoietin induced rapid healing of a chronic leg ulcer in a patient with sickle cell disease. Acta Haematologica. 1991; 86 (1):46–48.

    Google Scholar 

  22. Brooks BJ, Hanson DS, Cryer PA, Hubbard WJ, Hooper D. Erythropoietin therapy for sickle cell anemia in Jehovah's Witnesses. Southern Medical Journal. 1991; 84(11):1416–17.

    Google Scholar 

  23. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR. Effect of hydroxyurea on the frequency of painful crisis in sickle cell anemia. New England Journal of Medicine. 1995; 332(20):1317–22.

    Google Scholar 

  24. Deitch EA, Guillory D, Cruz N. Successful use of recombinant human erythropoietin in a Jehovah's Witness with a thermal injury. Journal of Burn Care and Rehabilitation. 1994; 15:42–45.

    Google Scholar 

  25. Dover GJ, Brusilow S, Charache S. Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood. 1994; 84(1):339–43.

    Google Scholar 

  26. Feola M, Simoni J, Angelillo R, Luhruma Z, Kabakele M, Manzombi M, Kaluila M. Clinical trial of a hemoglobin based blood substitute in patients with sickle cell anemia. Surgery, Gynecology and Obstetrics. 1992; 174:379–86.

    Google Scholar 

  27. Fibach E, Prasanna P, Rodgers GP, Samid D. Enhanced fetal hemoglobin production by phenylacetone and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and B-Thalassemia. Blood. 1993; 82(7):2203–2209.

    Google Scholar 

  28. Goldberg MA, Brugnara C, Dover GJ, Schapira L, Charache S, Bunn HF. Treatment of sickle cell anemia with hydroxyurea and erythropoietin. New England Journal of Medicine. 1990; 323(6):366–72.

    Google Scholar 

  29. Parker RI. Aggressive non-blood support of Jehovah's Witnesses. Critical Care Medicine. 1994; 22(3):381–82.

    Google Scholar 

  30. Pearlman ES, Ballas SK. When to transfuse blood in sickle cell disease: Lessons from Jehovah's Witnesses. Annals of Clinical and Laboratory Science. 1994; 24 (5):396–400.

    Google Scholar 

  31. Rodgers GP, Dover GJ, Uyesaka N, Noguchi CT, Schechter AN, Nienhuis AW. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. New England Journal of Medicine. 1993; 328(2):73–80.

    Google Scholar 

  32. Vogt PM, Kurz-Muller K, Peter FW, Buttemeyer R, Tryba M, Steinau HU. Preventing blood transfusion in a severely burned Jehovah's Witness (in German). Chirurg, 1995; 65 (11):1066–68.

    Google Scholar 

  33. Voskaridou E, Kalotychou V, Loukopoulos D. Clinical and laboratory effects of long-term administration of hydroxyurea to patients with sickle-cell/B Thalassaemia. British Journal of Haematology. 1995; 89:479–84.

    Google Scholar 

  34. Re I.D.K., 48 R.F.L. 2d 164, Ontario Province Court Family Division; 1985.

  35. Tierney WM, Weinberger M, Green JY, Studdard PA. Jehovah's Witnesses and blood transfusions: Physicians attitudes and legal precedents. Southern Medical Journal, 1984; 77(4):473–78.

    Google Scholar 

  36. Burck R. Burck scale of harm in ethical deliberation. Unpublished data. Rush University Medical Center, Department of Health and Human Values, Chicago, IL; 1995.

    Google Scholar 

  37. Jezewski MA. Culture brokering as a model for advocacy. Nursing and Health Care. 1993; 14(2):78–85.

    Google Scholar 

Download references

Authors
  1. Anita Catlin M.S.N., F.N.P.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Catlin, A. The dilemma of Jehovah's Witness children who need blood to survive. HEC Forum 8, 195–207 (1996). https://doi.org/10.1007/BF00056549

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00056549

Keywords

Search

Navigation